FDA Talent Hunt: Better To Recruit From Academia Than Industry?
This article was originally published in The Rose Sheet
CDER Oncology office head Richard Pazdur says making FDA more academic could help with retention. In addition to having fewer staff than needed to complete its work, FDA’s hiring problem makes it difficult for the agency to stay abreast of new scientific discoveries and technology.
You may also be interested in...
Only a handful of new FTEs are requested in President Obama’s FY 2016 budget request for human drugs activities, suggesting that GDUFA and other related programs may have reached their critical mass of employees for now.
FDA’s drug center continues to operate with a staffing shortage at a time of tremendous pressure to implement new authorities, with Director Janet Woodcock scrambling to find senior managers to lead top initiatives. Direct hiring authority has helped but doesn’t fully address FDA’s recruiting challenges: too much red tape and too little money.
Another outside candidate is expected to eventually take over for the departing director Gregory Geba, and while the Office of Generic Drugs can run smoothly without a permanent leader for now, it cannot do so forever.